Blood Products and Solutions | Battle n = 46 (78%) | Nonbattle n = 13 (22%) | Total n = 59 | p-value |
---|---|---|---|---|
IV Fluids | ||||
Crystalloid recipients | 22 (47.8%) | 4 (30.8%) | 26 (44.1%) | 0.35 |
Crystalloid units | 99.4 (0.35–13.6) | 4.2 (0.5–1.9) | 103.6 (0.35–13.6) | |
Colloid recipients | 4 (8.7%) | – | 4 (6.8%) | 0.56 |
Colloid units | 3 (0.25–1.75) | – | 3 (0.25–1.8) | |
Total recipients | 22 (47.8%) | 4 (30.8%) | 26 (44.1%) | 0.35 |
Total units | 102.4 (0.35–15.3) | 4.2 (0.5–1.9) | 106.6 (0.35–15.3) | |
Blood Products | ||||
Whole Blood recipients | 1 (2.2%) | – | 1 (1.7%) | 1.00 |
Whole Blood units | 4 | – | 4 | |
PRBCa recipients | 11 (23.9%) | 1 (7.7%) | 12 (20.3%) | 0.27 |
PRBC units | 121 (4–30) | 7 | 128 (4–30) | |
Platelets recipients | 6 (13%) | – | 6 (10.2%) | 0.32 |
Platelets units | 17 (1–6) | – | 17 (1–6) | |
Cryoprecipitate recipients | 5 (10.9%) | – | 5 (8.5%) | 0.58 |
Cryoprecipitate units | 86 (1–40) | – | 86 (1–40) | |
FFPb recipients | 12 (26.1%) | 1 (7.7%) | 13 (22%) | 0.26 |
FFP units | 111 (3–23) | 4 | 115 (3–23) | |
Total recipients | 13 (28.3%) | 1 (7.7%) | 14 (23.7%) | 0.16 |
Total units | 339 (4–73) | 11 | 350 (4–73) |